AutoImmune Inc. Announces the Market Launch of Colloral(R)

AutoImmune Inc. Announces the Market Launch of Colloral(R)
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Studies Show that FenuLife Lowers Blood Sugar Levels New Studies Show that FenuLife Lowers Blood Sugar Levels Restriction Or Ban Of Ephedra Supported By First Comparative Herbal Study NSF Dietary Supplements Program Certifies Theralogix(tm) Prostate 2.0 NSF Dietary Supplements Program Certifies Theralogix(tm) Prostate 2.0 NSF Dietary Supplements Program Certifies Theralogix(tm) Prostate 2.0 Organic Essentials Introduces The First Menstrual Pads with an Organic Cotton Core! New Topical Nutraceutical Now Available for Joints and Muscles HealtheTech Announces Distribution Relationship With World's Largest Retailer HealtheTech Announces Distribution Relationship With World's Largest Retailer Polyphenolics announces protection against atherosclerosis at AHA Presentation Impaired Glucose Metabolism And Memory Dysfunction Linked -- Phosphatidylserine (PS) And Alpha-Glyceryl Phosphoryl Choline (A-GPC) May Offer Answer Impaired Glucose Metabolism And Memory Dysfunction Linked -- Phosphatidylserine (PS) And Alpha-Glyceryl Phosphoryl Choline (A-GPC) May Offer Answer Impaired Glucose Metabolism And Memory Dysfunction Linked -- Phosphatidylserine (PS) And Alpha-Glyceryl Phosphoryl Choline (A-GPC) May Offer Answer SCOLR's First CDT Product to Be Carried by Two National Retail Chains; Second Quarter Introduction of CDT Glucosamine & Chondroitin in More Than 2,000 Stores Planned SCOLR's First CDT Product to Be Carried by Two National Retail Chains; Second Quarter Introduction of CDT Glucosamine & Chondroitin in More Than 2,000 Stores Planned The Quigley Corporation Plans to Submit IND for New Formulation Herbalife contemplates exports of mango flavoured protein mix Pilot Therapeutics to Market Airozin(TM) Pilot Therapeutics to Market Airozin(TM) ScienceBased Health's HydroEye(R) Awarded U.S Patent ScienceBased Health's HydroEye(R) Awarded U.S Patent Oasis Wellness Network Launches Revolutionary Joint Health Product Oasis Wellness Network Launches Revolutionary Joint Health Product Oasis Wellness Network Launches Revolutionary Joint Health Product New Hempseeds from Nutiva Loaded with Omega-3 (and Healthy Recipes) New Hempseeds from Nutiva Loaded with Omega-3 (and Healthy Recipes) Cognis' Exclusive Licensing Agreement with Natural ASA for TONALIN® CLA Goes into Effect Cognis' Exclusive Licensing Agreement with Natural ASA for TONALIN® CLA Goes into Effect Surya Henna Introduces A New Concept in Hair Coloring That Enhances Beauty While Protecting Health Surya Henna Introduces A New Concept in Hair Coloring That Enhances Beauty While Protecting Health NSF Certifies Amerifit Nutrition Sootherbs and FlexAble(tm) Brands NSF Certifies Amerifit Nutrition Sootherbs and FlexAble(tm) Brands SCOLR, Inc. to Ship First Order for BIO-tract G.I.; Introduction of First Targeted-Delivery Probiotic Product SCOLR, Inc. to Ship First Order for BIO-tract G.I.; Introduction of First Targeted-Delivery Probiotic Product Natto K2™ Branded Vitamin K Ingredient for Bone Health Now Available Exclusively From Natural Inc. Natto K2™ Branded Vitamin K Ingredient for Bone Health Now Available Exclusively From Natural Inc. Natto K2™ Branded Vitamin K Ingredient for Bone Health Now Available Exclusively From Natural Inc. NatraBio® Launches Nicotine Free Smoking Cessation Program NatraBio® Launches Nicotine Free Smoking Cessation Program Xenadrine Reaction on Baseball Player's Death Xenadrine Reaction on Baseball Player's Death Central Soya Broadens Its New Alpha Product Line By Adding A New Dispersible Soy Protein Product Alpha^TM 5812 Central Soya Broadens Its New Alpha Product Line By Adding A New Dispersible Soy Protein Product Alpha^TM 5812 FDA Okays Cargill Health & Food Technologies Request on Phytosterol Heart-Health Claim FDA announcement is good news for CoroWise™ phytosterols line FDA Okays Cargill Health & Food Technologies Request on Phytosterol Heart-Health Claim FDA announcement is good news for CoroWise™ phytosterols line FDA Okays Cargill Health & Food Technologies Request on Phytosterol Heart-Health Claim FDA announcement is good news for CoroWise™ phytosterols line FDA Okays Cargill Health & Food Technologies Request on Phytosterol Heart-Health Claim FDA announcement is good news for CoroWise™ phytosterols line FDA Okays Cargill Health & Food Technologies Request on Phytosterol Heart-Health Claim FDA announcement is good news for CoroWise™ phytosterols line NSF International Certifies Kmart Vitasmart(R) Brand NSF International Certifies Kmart Vitasmart(R) Brand Linnea Quality Reflected in Expanded Product Line Linnea Quality Reflected in Expanded Product Line Award-Winning Moducare Now Available In Grape Flavour Chewable Cargill Health & Food Technologies to Launch CoroWise™ Phytosterols and Showcase Ascend™ Trehalose at Nutracon-SupplyExpo Cargill Health & Food Technologies to Launch CoroWise™ Phytosterols and Showcase Ascend™ Trehalose at Nutracon-SupplyExpo Cargill Health & Food Technologies to Launch CoroWise™ Phytosterols and Showcase Ascend™ Trehalose at Nutracon-SupplyExpo Amazon Acai Brings All Natural Energy to the Los Angeles Marathon Amazon Acai Brings All Natural Energy to the Los Angeles Marathon SCOLR, Inc. Announces Global Probiotic Manufacturing Contract; Commences Shipments to Selected VRI Marketing Territories, With Additional Markets Planned SCOLR, Inc. Announces Global Probiotic Manufacturing Contract; Commences Shipments to Selected VRI Marketing Territories, With Additional Markets Planned Kashi(R) Gets to the Heart of the Matter With New Heart to Heart(TM) Cereal Kashi(R) Gets to the Heart of the Matter With New Heart to Heart(TM) Cereal Osteo Bi-Flex(R) Answers Consumers' Joint Care Needs With Enhanced Formulas, Easier-To-Swallow Technology And Easy-To-Open Packaging Osteo Bi-Flex(R) Answers Consumers' Joint Care Needs With Enhanced Formulas, Easier-To-Swallow Technology And Easy-To-Open Packaging Osteo Bi-Flex(R) Answers Consumers' Joint Care Needs With Enhanced Formulas, Easier-To-Swallow Technology And Easy-To-Open Packaging Powdered Oils, A Nutritional Breakthrough Gaffney Signs Historic Law Banning Ephedra Products Gaffney Signs Historic Law Banning Ephedra Products Gaffney Signs Historic Law Banning Ephedra Products General Nutrition Centers, Inc. Reports FY09 Q3 Results General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008. General Nutrition Centers, Inc. Reports FY09 Q3 Results General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008. General Nutrition Centers, Inc. Reports FY09 Q3 Results General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. Senomyx Announces Corporate Update and FY09 Q3 Results Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. GLG Life Tech Corporation Announces Receipt of Demand Letter GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. Ingredients Manufacturer Goes Small Taura Natural Ingredients has announced their new Mini Fruit Bits. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. MGP Ingredients, Inc. Announces FY10 Q1 Results MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. Whole Foods Market Reports FY09 Q4 Results Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults. New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults.	PASADENA, Calif., Feb. 18 /PRNewswire-FirstCall/ -- AutoImmune Inc. (Nasdaq: AIMM) today announced that its joint venture with Deseret Laboratories International has begun direct sales of Colloral(R), a product for the nutritional support of patients with rheumatoid arthritis. The new product can be purchased over the internet at ColloralLLC.com or by contacting Colloral LLC at 1414 East 3850 South, St. George, UT 84790 (toll free 1-877-284-7246). Robert C. Bishop, Ph.D., Chairman of the Board and Chief Executive Officer, stated "Colloral(R) has undergone extensive clinical testing which demonstrated its unique formulation of undenatured Type II collegen to be remarkably safe and of substantial benefit to a large number of patients." All of the development work on Colloral(R) was done under IND's by AutoImmune and its collaborators who originally anticipated marketing the product as a pharmaceutical. The company transitioned the product to the nutritional supplement category by filing a "Notice of New Dietary Ingredient" with the FDA. AutoImmune is a biopharmaceutical company involved in the development of a new class of mucosally administered therapies for the treatment of autoimmune and cell-mediated inflammatory diseases and conditions. This release contained forward-looking statements which involve risks and uncertainties. The Company's actual results may differ significantly from results discussed in the forward-looking statements due to a number of important factors, including, but not limited to the uncertainties of clinical trial results, the Company's dependence on third parties for licensing revenue, and the risks of technological change and competition. These factors are more fully discussed in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission in the section "Business-Factors to be Considered." The discussion in the Annual Report on Form 10-K is hereby referenced into this release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software